Use of Adjunctive Treatment with Interferon- in an Immunocompromised Patient Who Had Refractory Multidrug-Resistant Tuberculosis of the Brain
Author(s) -
Issam Raad,
Ramsey R. Hachem,
Norman E. Leeds,
Raja Sawaya,
Ziad Salem,
Samir Atweh
Publication year - 1996
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/clinids/22.3.572
Subject(s) - medicine , tuberculosis , refractory (planetary science) , radiological weapon , adjunctive treatment , spinal cord , surgery , pathology , physics , psychiatry , astrobiology
We describe a patient with acute lymphocytic leukemia and multidrug-resistant tuberculosis of the brain and spinal cord. Despite treatment with six antituberculous drugs and a steroid medication for 11 months, there was no appreciable clinical or radiological improvement in the patient's condition. Within 5 months of initiating adjunctive therapy with IFN-gamma and granulocyte colony stimulating factors, substantial neurological and radiological improvement was noted. Therapy with IFN-gamma was continued for 12 months, resulting in complete resolution of the lesions in the brain and spinal cord.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom